Stockrabit · Analysts
Questions across 1 call

Gaurav Tinani

Ambit Capital

Dr. Lal Path Labs Ltd.

Dr. Lal Path Labs Ltd. CC-May26.pdf · 2026-04-30
Hi, good evening, and thank you. Question is on the incorporation of the subsidiary in Dubai, UAE. Can you share what are your plans from a business build-out in these geographies? And what percentage of capital or capex of Rs. 120 crore, if any, is allocated to this geography as well in FY27?
You have significant cash on balance sheet. Would inorganic opportunities be also explored in the Middle East or Dubai, UAE markets over the next 2 -3 years, you would be open to that?